Stanley T. Crooke

2016

In 2016, Stanley T. Crooke earned a total compensation of $9.2M as Chairman, President, Chief Executive Officer at Ionis Pharmaceuticals, a 15% increase compared to previous year.

Compensation breakdown

Bonus$1,205,882
Option Awards$5,705,552
Salary$824,535
Stock Awards$1,427,416
Other$25,366
Total$9,188,751

Crooke received $5.7M in option awards, accounting for 62% of the total pay in 2016.

Crooke also received $1.2M in bonus, $824.5K in salary, $1.4M in stock awards and $25.4K in other compensation.

Rankings

In 2016, Stanley T. Crooke's compensation ranked 603rd out of 14,075 executives tracked by ExecPay. In other words, Crooke earned more than 95.7% of executives.

ClassificationRankingPercentile
All
603
out of 14,075
96th
Division
Manufacturing
195
out of 5,488
96th
Major group
Chemicals And Allied Products
45
out of 1,900
98th
Industry group
Drugs
29
out of 1,543
98th
Industry
Pharmaceutical Preparations
21
out of 1,173
98th
Source: SEC filing on April 10, 2017.

Crooke's colleagues

We found five more compensation records of executives who worked with Stanley T. Crooke at Ionis Pharmaceuticals in 2016.

2016

B Parshall

Ionis Pharmaceuticals

Chief Operating Officer

2016

Brett Monia

Ionis Pharmaceuticals

Senior Vice President,

2016

Richard Geary

Ionis Pharmaceuticals

Senior Vice President, Development

2016

Patrick O'Neil

Ionis Pharmaceuticals

General Counsel

2016

Elizabeth Hougen

Ionis Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like